NCT07157865 Comparing Prism Adaptation Training With and Without TENS to Minimize Unilateral Spatial Neglect
| NCT ID | NCT07157865 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kettering Health Network |
| Condition | Unilateral Spatial Neglect |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2025-09-30 |
| Primary Completion | 2028-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2025-09-30 with a primary completion date of 2028-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to find out if doing two treatments together-Prism Adaptation Therapy (PAT) and Transcutaneous Electrical Nerve Stimulation (TENS)-will help people who have had a stroke pay better attention to one side of their body, better than just doing PAT by itself. In addition to understanding how the intervention improves function the investigators would like to see if things like how old someone is, how long ago their stroke happened, where their brain was damaged, or how bad the neglect is, affect how well the treatment works. To measure if the interventions make a difference the following outcome measures will be used. Catherine Bergego Scale (CBS): This is a test to see how severe someone's neglect is. Trained therapists use 10 simple tasks to check if a person is ignoring the left or right side. Wolf Motor Function Test (WMFT): This test checks how well a stroke survivor can move their arm. It helps the therapists see if the treatments improve movement and reaction time People can join the study if they had a stroke, score at least "1" on the Catherine Bergego Scale, and they can understand and agree to take part in the study. People cannot join the study if they have had more than two strokes, have or had seizures, or have a serious mental illness like schizophrenia, or have cancer in the arm that was affected by the stroke, they have a pacemaker or defibrillator in their body, and if they can't feel their arm on the side affected by the stroke Once the study is done, the main results will be shared with the therapists who work at the NeuroRehab and Balance Center, like the physical, speech, and occupational therapists.
Eligibility Criteria
Inclusion Criteria: * A diagnosis of stroke * Score 1 or above on the Catherine Bergego Scale * Cognitively able to consent Exclusion Criteria: * Seizure disorder * Diagnosed with more than two strokes * Diagnosis of schizophrenia or schizoaffective disorder * Cancer diagnosis of upper extremity * Individuals with pacemakers and debrillators * Absent sensation of upper extremity affected by stroke
Contact & Investigator
Rachelle M Janning, OTD, MS, OTR/L
PRINCIPAL INVESTIGATOR
Kettering Health/Northern Kentucky University
Frequently Asked Questions
Who can join the NCT07157865 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Unilateral Spatial Neglect. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07157865 currently recruiting?
Yes, NCT07157865 is actively recruiting participants. Contact the research team at rachelle.janning@ketteringhealth.org for enrollment information.
Where is the NCT07157865 trial being conducted?
This trial is being conducted at Centerville, United States, Centerville, United States.
Who is sponsoring the NCT07157865 clinical trial?
NCT07157865 is sponsored by Kettering Health Network. The principal investigator is Rachelle M Janning, OTD, MS, OTR/L at Kettering Health/Northern Kentucky University. The trial plans to enroll 20 participants.